Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance

SIMPLE SUMMARY: Many patients with the aggressive cancer diffuse large B-cell lymphoma (DLBCL) still respond poorly to treatment and suffer from relapsed or refractory disease. The identification of gene mutations that are responsible for the outgrowth of the relapsed tumor is crucial to understand...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Berendsen, Madeleine R., Stevens, Wendy B. C., van den Brand, Michiel, van Krieken, J. Han, Scheijen, Blanca
Aineistotyyppi: Online Artikkeli Teksti
Kieli:English
Julkaistu: MDPI 2020
Aiheet:
Review
Linkit:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760867/
https://www.ncbi.nlm.nih.gov/pubmed/33260693
http://dx.doi.org/10.3390/cancers12123553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760867/
https://www.ncbi.nlm.nih.gov/pubmed/33260693
http://dx.doi.org/10.3390/cancers12123553

Samankaltaisia teoksia